- Company Directors - S
- Schreiber Alain
Insider Trading History of Schreiber Alain
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Schreiber Alain since 2005.
The trader's CIK number is 1225149.
At the time of the last reporting, Schreiber Alain was the Director of Urogen Pharma Ltd.. (stock ticker symbol URGN).
Also see all insider trading activities at Urogen Pharma Ltd..
Note that in the past
SCHREIBER ALAIN also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Avanir Pharmaceuticals (AVNR) by Schreiber Alain
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2009 | AVNR | 0 | $0 | 2,673,112 | $7,306,198 | 0 | $0 |
2008 | AVNR | 2,070,176 | $1,728,933 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Eagle Pharmaceuticals, Inc. (EGRX) by Schreiber Alain
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2017 | EGRX | 0 | $0 | 418,294 | $35,084,237 | 54,180 | $925,719 |
2016 | EGRX | 0 | $0 | 833,471 | $58,338,739 | 0 | $0 |
2014 | EGRX | 333,333 | $4,999,995 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Optimer Pharmaceuticals Inc (OPTR) by Schreiber Alain
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2009 | OPTR | 457,666 | $0 | 0 | $0 | 0 | $0 |
2008 | OPTR | 943,396 | $7,999,998 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Molecular Templates, Inc. (THLD) by Schreiber Alain
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2005 | THLD | 0 | $0 | 110,364 | $1,154,407 | 0 | $0 |
Yearly summary of insider trading at Palatin Technologies Inc (PTN) by Schreiber Alain
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2005 | PTN | 0 | $0 | 358,000 | $1,405,150 | 0 | $0 |
Yearly summary of insider trading at Cadence Pharmaceuticals Inc (CADX) by Schreiber Alain
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2007 | CADX | 0 | $0 | 114,200 | $1,602,565 | 0 | $0 |
Yearly summary of insider trading at Immune Design Corp. (IMDZ) by Schreiber Alain
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2015 | IMDZ | 0 | $0 | 711,899 | $17,988,019 | 0 | $0 |
Yearly summary of insider trading at Urogen Pharma Ltd. (URGN) by Schreiber Alain
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2017 | URGN | 0 | $0 | 209,298 | $8,497,870 | 0 | $0 |
Yearly summary of insider trading at Novadel Pharma Inc (NVD) by Schreiber Alain
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2007 | NVD | 961,914 | $1,394,775 | 0 | $0 | 0 | $0 |
2006 | NVD | 689,656 | $1,000,001 | 0 | $0 | 0 | $0 |
Insider trading activities at 9 companies by Schreiber Alain:
1. Avanir Pharmaceuticals (AVNR)
2. Eagle Pharmaceuticals, Inc. (EGRX)
3. Optimer Pharmaceuticals Inc (OPTR)
4. Molecular Templates, Inc. (THLD)
5. Palatin Technologies Inc (PTN)
6. Cadence Pharmaceuticals Inc (CADX)
7. Immune Design Corp. (IMDZ)
8. Urogen Pharma Ltd. (URGN)
9. Novadel Pharma Inc (NVD)
Table 1. Insider trading of Avanir Pharmaceuticals (AVNR) by Schreiber Alain
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2009-10-12 | AVNR | Sale | 427,145 | 2.12 | 905,547 |
2009-10-09 | AVNR | Sale | 804,712 | 2.46 | 1,979,591 |
2009-10-13 | AVNR | Sale | 547,135 | 2.23 | 1,220,111 |
2009-08-11 | AVNR | Sale | 894,120 | 3.58 | 3,200,949 |
2008-10-22 | AVNR | Buy | 10,600 | .48 | 5,088 |
2008-10-14 | AVNR | Buy | 32,300 | .50 | 16,150 |
2008-10-15 | AVNR | Buy | 6,465 | .49 | 3,167 |
2008-10-10 | AVNR | Buy | 73,551 | .45 | 33,097 |
2008-10-07 | AVNR | Buy | 21,318 | .48 | 10,232 |
2008-10-08 | AVNR | Buy | 114,384 | .50 | 57,192 |
2008-10-09 | AVNR | Buy | 41,385 | .48 | 19,864 |
2008-09-17 | AVNR | Buy | 413,217 | .80 | 330,573 |
2008-09-16 | AVNR | Buy | 17,387 | .76 | 13,214 |
2008-09-15 | AVNR | Buy | 244,449 | .85 | 207,781 |
2008-09-08 | AVNR | Buy | 125,000 | .95 | 118,750 |
2008-09-09 | AVNR | Buy | 146,400 | .92 | 134,688 |
2008-09-10 | AVNR | Buy | 48,103 | .91 | 43,773 |
2008-09-03 | AVNR | Buy | 6,864 | .93 | 6,383 |
2008-09-02 | AVNR | Buy | 323,550 | .93 | 300,901 |
2008-09-04 | AVNR | Buy | 52,113 | .95 | 49,507 |
2008-08-27 | AVNR | Buy | 89,447 | .95 | 84,974 |
2008-08-14 | AVNR | Buy | 6,051 | .90 | 5,445 |
2008-08-15 | AVNR | Buy | 114,032 | .95 | 108,330 |
2008-08-07 | AVNR | Buy | 91,380 | .98 | 89,552 |
2008-08-07 | AVNR | Buy | 91,380 | .98 | 89,552 |
2008-08-06 | AVNR | Buy | 400 | .90 | 360 |
2008-08-06 | AVNR | Buy | 400 | .90 | 360 |
Table 2. Insider trading of Eagle Pharmaceuticals, Inc. (EGRX) by Schreiber Alain
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2017-04-25 | EGRX | Option Ex | 54,180 | 17.09 | 925,719 |
2017-04-25 | EGRX | Sale | 54,180 | 88.72 | 4,806,578 |
2017-04-03 | EGRX | Sale | 61,420 | 83.13 | 5,105,844 |
2017-03-31 | EGRX | Sale | 23,689 | 83.02 | 1,966,660 |
2017-03-30 | EGRX | Sale | 6,223 | 83.00 | 516,509 |
2017-03-29 | EGRX | Sale | 60,855 | 83.01 | 5,051,573 |
2017-03-27 | EGRX | Sale | 39,431 | 83.00 | 3,272,773 |
2017-03-28 | EGRX | Sale | 6,182 | 83.02 | 513,229 |
2017-03-21 | EGRX | Sale | 500 | 83.10 | 41,550 |
2017-03-23 | EGRX | Sale | 700 | 83.01 | 58,107 |
2017-03-16 | EGRX | Sale | 9,120 | 82.08 | 748,569 |
2017-03-20 | EGRX | Sale | 51,883 | 82.10 | 4,259,594 |
2017-03-17 | EGRX | Sale | 38,997 | 82.01 | 3,198,143 |
2017-01-04 | EGRX | Sale | 65,114 | 85.16 | 5,545,108 |
2016-11-10 | EGRX | Sale | 18,935 | 85.70 | 1,622,767 |
2016-11-11 | EGRX | Sale | 15,551 | 85.00 | 1,321,835 |
2016-11-09 | EGRX | Sale | 148,800 | 77.81 | 11,578,574 |
2016-11-07 | EGRX | Sale | 5,030 | 75.39 | 379,211 |
2016-11-02 | EGRX | Sale | 199,600 | 70.10 | 13,992,359 |
2016-11-04 | EGRX | Sale | 46,170 | 75.00 | 3,462,750 |
2016-09-30 | EGRX | Sale | 22,100 | 70.06 | 1,548,326 |
2016-09-29 | EGRX | Sale | 77,900 | 70.04 | 5,456,116 |
2016-09-21 | EGRX | Sale | 99,795 | 66.43 | 6,629,681 |
2016-09-06 | EGRX | Sale | 25,397 | 62.84 | 1,595,947 |
2016-09-08 | EGRX | Sale | 34,086 | 62.33 | 2,124,580 |
2016-09-07 | EGRX | Sale | 11,442 | 62.26 | 712,378 |
2016-08-23 | EGRX | Sale | 17,265 | 63.13 | 1,089,887 |
2016-08-24 | EGRX | Sale | 11,605 | 62.78 | 728,561 |
2016-08-17 | EGRX | Sale | 14,696 | 61.01 | 896,602 |
2016-08-16 | EGRX | Sale | 60,150 | 61.22 | 3,682,142 |
2016-08-15 | EGRX | Sale | 24,949 | 60.80 | 1,517,023 |
2014-02-18 | EGRX | Buy | 333,333 | 15.00 | 4,999,995 |
Table 3. Insider trading of Optimer Pharmaceuticals Inc (OPTR) by Schreiber Alain
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2009-03-04 | OPTR | Buy | 457,666 | .00 | 0 |
2008-07-18 | OPTR | Buy | 943,396 | 8.48 | 7,999,998 |
Table 4. Insider trading of Molecular Templates, Inc. (THLD) by Schreiber Alain
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2005-10-28 | THLD | Sale | 110,364 | 10.46 | 1,154,407 |
Table 5. Insider trading of Palatin Technologies Inc (PTN) by Schreiber Alain
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2005-11-29 | PTN | Sale | 358,000 | 3.92 | 1,405,150 |
Table 6. Insider trading of Cadence Pharmaceuticals Inc (CADX) by Schreiber Alain
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2007-09-18 | CADX | Sale | 7,900 | 13.50 | 106,650 |
2007-09-17 | CADX | Sale | 200 | 13.50 | 2,700 |
2007-09-19 | CADX | Sale | 74,300 | 13.99 | 1,039,679 |
2007-09-19 | CADX | Sale | 28,800 | 14.33 | 412,704 |
2007-09-12 | CADX | Sale | 2,500 | 13.63 | 34,082 |
2007-09-14 | CADX | Sale | 500 | 13.50 | 6,750 |
Table 7. Insider trading of Immune Design Corp. (IMDZ) by Schreiber Alain
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2015-05-12 | IMDZ | Sale | 177,607 | 21.88 | 3,886,041 |
2015-04-22 | IMDZ | Sale | 25,249 | 26.56 | 670,613 |
2015-04-23 | IMDZ | Sale | 32,643 | 27.00 | 881,197 |
2015-04-24 | IMDZ | Sale | 25,000 | 26.64 | 666,000 |
2015-04-17 | IMDZ | Sale | 18,861 | 26.67 | 503,022 |
2015-04-20 | IMDZ | Sale | 12,792 | 26.44 | 338,220 |
2015-04-21 | IMDZ | Sale | 14,167 | 26.35 | 373,300 |
2015-04-14 | IMDZ | Sale | 13,814 | 27.26 | 376,569 |
2015-04-15 | IMDZ | Sale | 40,000 | 28.87 | 1,154,800 |
2015-04-16 | IMDZ | Sale | 100 | 26.75 | 2,675 |
2015-04-06 | IMDZ | Sale | 3,895 | 26.88 | 104,697 |
2015-04-07 | IMDZ | Sale | 3,600 | 26.55 | 95,580 |
2015-04-01 | IMDZ | Sale | 62,454 | 26.38 | 1,647,349 |
2015-03-24 | IMDZ | Sale | 13,200 | 27.67 | 365,244 |
2015-03-25 | IMDZ | Sale | 4,956 | 27.56 | 136,587 |
2015-03-23 | IMDZ | Sale | 5,000 | 27.78 | 138,900 |
2015-03-19 | IMDZ | Sale | 30,000 | 27.81 | 834,300 |
2015-03-20 | IMDZ | Sale | 9,464 | 27.88 | 263,837 |
2015-03-16 | IMDZ | Sale | 10,309 | 25.43 | 262,157 |
2015-03-17 | IMDZ | Sale | 20,000 | 25.94 | 518,800 |
2015-03-18 | IMDZ | Sale | 20,000 | 26.90 | 538,040 |
2015-03-11 | IMDZ | Sale | 29,000 | 25.02 | 725,580 |
2015-03-12 | IMDZ | Sale | 94,199 | 24.94 | 2,349,323 |
2015-03-10 | IMDZ | Sale | 6,143 | 24.65 | 151,424 |
2015-03-09 | IMDZ | Sale | 32,300 | 25.61 | 827,203 |
2015-03-06 | IMDZ | Sale | 1,146 | 25.01 | 28,661 |
2015-03-05 | IMDZ | Sale | 6,000 | 24.65 | 147,900 |
Table 8. Insider trading of Urogen Pharma Ltd. (URGN) by Schreiber Alain
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2017-11-27 | URGN | Sale | 31,491 | 41.12 | 1,294,909 |
2017-11-28 | URGN | Sale | 177,807 | 40.51 | 7,202,961 |
Table 9. Insider trading of Novadel Pharma Inc (NVD) by Schreiber Alain
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2007-01-05 | NVD | Buy | 961,914 | 1.45 | 1,394,775 |
2006-04-12 | NVD | Buy | 689,656 | 1.45 | 1,000,001 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Schreiber Alain
(Director of Urogen Pharma Ltd. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.